1. Home
  2. BNTC vs BNED Comparison

BNTC vs BNED Comparison

Compare BNTC & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • BNED
  • Stock Information
  • Founded
  • BNTC 1995
  • BNED 1965
  • Country
  • BNTC United States
  • BNED United States
  • Employees
  • BNTC N/A
  • BNED N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • BNED Other Specialty Stores
  • Sector
  • BNTC Health Care
  • BNED Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • BNED Nasdaq
  • Market Cap
  • BNTC 339.8M
  • BNED 310.9M
  • IPO Year
  • BNTC N/A
  • BNED N/A
  • Fundamental
  • Price
  • BNTC $15.66
  • BNED $9.95
  • Analyst Decision
  • BNTC Strong Buy
  • BNED Hold
  • Analyst Count
  • BNTC 7
  • BNED 1
  • Target Price
  • BNTC $24.43
  • BNED N/A
  • AVG Volume (30 Days)
  • BNTC 37.6K
  • BNED 392.5K
  • Earning Date
  • BNTC 05-12-2025
  • BNED 03-10-2025
  • Dividend Yield
  • BNTC N/A
  • BNED N/A
  • EPS Growth
  • BNTC N/A
  • BNED N/A
  • EPS
  • BNTC N/A
  • BNED N/A
  • Revenue
  • BNTC N/A
  • BNED $1,567,800,000.00
  • Revenue This Year
  • BNTC N/A
  • BNED $2.74
  • Revenue Next Year
  • BNTC N/A
  • BNED N/A
  • P/E Ratio
  • BNTC N/A
  • BNED N/A
  • Revenue Growth
  • BNTC N/A
  • BNED N/A
  • 52 Week Low
  • BNTC $4.75
  • BNED $6.05
  • 52 Week High
  • BNTC $15.97
  • BNED $135.00
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 73.53
  • BNED 52.37
  • Support Level
  • BNTC $11.99
  • BNED $9.51
  • Resistance Level
  • BNTC $15.97
  • BNED $10.17
  • Average True Range (ATR)
  • BNTC 1.03
  • BNED 0.64
  • MACD
  • BNTC 0.33
  • BNED 0.13
  • Stochastic Oscillator
  • BNTC 93.76
  • BNED 89.03

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: